(Q36958344)

17 August 2017

1 reference

title

Interleukin-20 as a target in psoriasis treatment (English)

1 reference

17 August 2017

Karin Stenderup

1

1 reference

17 August 2017

Cecilia Rosada

2

1 reference

17 August 2017

Anne Worsaae

3

1 reference

17 August 2017

Jes Thorn Clausen

4

1 reference

17 August 2017

Tomas Norman Dam

5

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

Annals of the New York Academy of Sciences

17 August 2017

published in

1 reference

17 August 2017

volume

1110

1 reference

17 August 2017

page(s)

368-381

1 reference

Lifestyle of Nordic people with psoriasis

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Biological therapies in the systemic management of psoriasis: International Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Recommendations for the topical treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Interleukin 20: discovery, receptor identification, and role in epidermal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10)

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

The melanoma differentiation associated gene mda-7 suppresses cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Immunopathogenic mechanisms in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Disease mimicry--a pathogenetic concept for T cell-mediated autoimmune disorders triggered by molecular mimicry?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Psoriasis: dysregulation of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

The pathogenic role of tissue-resident immune cells in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Development and use of alefacept to treat psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

The immunologic basis for the treatment of psoriasis with new biologic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

The family of IL-10-related cytokines and their receptors: related, but to what extent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Characterization of the Recombinant Extracellular Domains of Human Interleukin-20 Receptors and Their Complexes with Interleukin-19 and Interleukin-20

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Cytokines: IL-20 - a new effector in skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Human fetal membrane expression of IL-19 and IL-20 and its differential effect on inflammatory cytokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Ultraviolet B light stimulates interleukin-20 expression by human epithelial keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

The interleukin-10 family of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Bacterial endotoxin induces IL-20 expression in the glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.039

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1423.039

1 reference

17 August 2017

1 reference